Investors / Korify Capital
Korify Capital
Venture capital
Korify Capital is an investment firm focused on biotechnology and healthcare. It backs companies in longevity, mental health and regenerative medicine across three strategies: distributed development companies, enabling technologies and domain-specific platforms.
Invests inHealthcare & Biotech
In its own wordsbiotechlongevitymental healthregenerative medicinedrug discoveryhealthcare
Your fit with Korify Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsKorify Capital lists 11 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (83%), Education (8%) and Enterprise Software (8%). 80% of its companies are based in United States. It invests most often alongside Apollo Health Ventures, Catalio Capital Management and Future Ventures.
No funding round on record names Korify Capital yet, so the figures come from its portfolio page.
Round figures show recent activity, not Korify Capital's whole history. Rounds on record name 0 companies; its own site lists 11. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 94th | 83% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers11100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 83% | 15% |
| Education | 8% | 7% |
| Enterprise Software | 8% | 8% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Apollo Health Ventures
Compare Korify Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aera Health organizes and analyzes patient data in real-time, enabling proactive, personalized health solutions. | Healthcare & Biotech | Portfolio page | ||
| Alto Neuroscience develops biology-driven medicines for neuropsychiatric conditions | Healthcare & Biotech | Portfolio page | ||
| Booster Therapeutics develops therapeutics to restore the cell's natural quality control machinery to treat complex diseases | Healthcare & Biotech | Portfolio page | ||
| Cambrian Biopharma is developing drugs targeting the underlying drivers of metabolic decline and dysfunction | Healthcare & Biotech | Portfolio page | ||
| Centenara Labs develops and invests in therapies that target geriatric diseases. | Healthcare & Biotech | Portfolio page | ||
| Cleara Biotech is a biopharmaceutical research and development company focused on developing peptide-based therapies against cancer and chronic diseases. | Healthcare & Biotech | Portfolio page | ||
| Gameto is a biotechnology company that develops innovative solutions for women's reproductive health, including treatments for infertility and menopause. | Healthcare & Biotech | Portfolio page | ||
| Nula Therapeutics is pioneering a new class of medicines to treat metabolic dysfunction, neurodegeneration, and cancer | Healthcare & Biotech | Portfolio page | ||
| Refoxy develops next-generation medicines to treat age-related diseases and extend the number of years people can live in good health. | Healthcare & Biotech | Portfolio page | ||
| Samsara Therapeutics is working on treating neurodegenerative diseases by improving autophagy. | Healthcare & Biotech | Portfolio page | ||
| The company produces and sells a screen-free audio learning system for children. | EducationEnterprise Software | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- korifycapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Korify Capital's profile as data
Pull Korify Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/korifycapital.com
# also
GET /v1/firms/korifycapital.com/portfolio
GET /v1/firms/korifycapital.com/coinvestors
GET /v1/firms/korifycapital.com/news